Name-brand semaglutide injections normally require refrigeration before opening up to the expiration date, but can be stored at room temperature for almost four weeks if needed

The GWAS summary statistics for MTDS were obtained from the 10th release of the FinnGen consortium, including colon adenocarcinoma (3,212 cases, 314,193 controls), malignant neoplasm of colon (4,143 cases), colorectal adenocarcinoma (5,610 cases), colorectal cancer (6,847 cases), hepatocellular carcinoma (500 cases), malignant neoplasm of oesophagus (619 cases), adenocarcinoma and ductal carcinoma of pancreas (731 cases), malignant neoplasm of pancreas (1,626 cases), adenocarcinoma and papilloma adenocarcinoma of rectum (2,437 cases), adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum (2, 545 cases), malignant neoplasm of rectum (2,490 cases), malignant neoplasm of small intestine (525 cases), adenocarcinoma and papillary adenocarcinoma of stomach (792 cases), and malignant neoplasm of stomach (1,423 cases)

Highlights Glucagon-like peptide-1 (GLP-1) is a 30-amino acid peptide hormone produced by intestinal L cells through differential processing of the proglucagon (PG) gene [1]
Alongside the semaglutide, each tablet contains a small number of inactive ingredients
Analytical verification is harder